Flex Earns Acclaim from Frost & Sullivan for Harnessing Its Cross-industry Influence and R&D Prowess to Aid Reliable Medical Device Production

The company leverages a strong partnership network to offer support for cutting-edge medical device design and manufacturing

LONDON, United Kingdom, July 23, 2019 /PRNewswire/ -- Based on its recent analysis of the global medical device design and manufacturing support solutions market, Frost & Sullivan recognises Flex Health Solutions with the 2019 Global Company of the Year Award. With thousands of professionals across 30 countries, rigorous research and development processes, and an impressive set of partners, Flex Health Solutions is at the cutting-edge of technology. Flex Health Solutions is a business unit of Flex Ltd, a global contract manufacturer of technology-centred products, with experience in medical, communications, automotive, and other industries. Flex leverages this foundation in electronics manufacturing to digitise medical and other devices, as well as create smart devices and applications.

Photo - https://mma.prnewswire.com/media/950279/Flex_Award.jpg

Flex not only serves as a contract manufacturer but also partners with companies in the concept and design phases. For example, it partnered with Novocure to refine the product design and manufacturing processes for the Optune system, which creates an electromagnetic field that inhibits the growth of glioblastoma (brain cancer). Novocure, which had significant knowledge of the pathology of the disease and the mechanism of therapy, leveraged Flex's expertise in design and manufacturing to create a highly wearable product.

"The company has a single quality management system across all its medical sites, which streamlines the production transfers from one site to another without complications, documentation gaps, or compromised quality," said Siddharth Shah, Industry Analyst at Frost & Sullivan. "Importantly, Flex helps to design the product to meet cost targets and manufacturability while simultaneously building technologies for the future. For instance, its FDA- and HIPPA-compliant back-end platform, BrightInsight, leverages artificial intelligence to create algorithms from existing data to support digital health."